Li Lu

1.8k total citations · 1 hit paper
23 papers, 1.4k citations indexed

About

Li Lu is a scholar working on Molecular Biology, Cell Biology and Cancer Research. According to data from OpenAlex, Li Lu has authored 23 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 5 papers in Cell Biology and 4 papers in Cancer Research. Recurrent topics in Li Lu's work include Hippo pathway signaling and YAP/TAZ (5 papers), Wnt/β-catenin signaling in development and cancer (5 papers) and Virus-based gene therapy research (2 papers). Li Lu is often cited by papers focused on Hippo pathway signaling and YAP/TAZ (5 papers), Wnt/β-catenin signaling in development and cancer (5 papers) and Virus-based gene therapy research (2 papers). Li Lu collaborates with scholars based in China, United States and Hong Kong. Li Lu's co-authors include Randy L. Johnson, Milton J. Finegold, Ju‐Seog Lee, Pu Liu, Qiong Qiu, Wouter Bossuyt, Ying Li, Georg Halder, Yingdi Wang and Soo Mi Kim and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Hepatology.

In The Last Decade

Li Lu

22 papers receiving 1.3k citations

Hit Papers

Hippo signaling is a potent in vivo growth and tumor supp... 2010 2026 2015 2020 2010 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Li Lu China 14 845 708 154 147 143 23 1.4k
Arianna Pocaterra Italy 9 598 0.7× 639 0.9× 20 0.1× 171 1.2× 203 1.4× 12 1.1k
Matt Fish United States 10 991 1.2× 196 0.3× 470 3.1× 161 1.1× 82 0.6× 13 1.5k
Detian Yuan China 14 549 0.6× 84 0.1× 82 0.5× 137 0.9× 135 0.9× 19 859
V. C. Padmakumar United States 11 1.1k 1.3× 401 0.6× 33 0.2× 151 1.0× 100 0.7× 12 1.4k
Nicolas Gadot France 20 520 0.6× 126 0.2× 30 0.2× 197 1.3× 108 0.8× 46 990
Chengjian Zhao China 17 441 0.5× 185 0.3× 28 0.2× 130 0.9× 184 1.3× 42 792
Alexandra Demory Germany 10 323 0.4× 93 0.1× 158 1.0× 185 1.3× 61 0.4× 15 830
Markus Morkel Germany 21 1.0k 1.2× 90 0.1× 144 0.9× 420 2.9× 262 1.8× 33 1.6k
Takahisa Hachiya Japan 19 1.2k 1.4× 124 0.2× 92 0.6× 98 0.7× 100 0.7× 27 1.6k
Fumiko Marttila‐Ichihara Finland 11 479 0.6× 206 0.3× 16 0.1× 237 1.6× 78 0.5× 13 1.0k

Countries citing papers authored by Li Lu

Since Specialization
Citations

This map shows the geographic impact of Li Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Lu more than expected).

Fields of papers citing papers by Li Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Lu. The network helps show where Li Lu may publish in the future.

Co-authorship network of co-authors of Li Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Li Lu. A scholar is included among the top collaborators of Li Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Lu. Li Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xia, Haishan, et al.. (2025). The Fundamental Issues and Development Trends of AI-Driven Transformations in Urban Transit and Urban Space. Sustainable Cities and Society. 126. 106422–106422. 4 indexed citations
4.
Lu, Li, Aolin Zhang, Ling Wang, et al.. (2021). Evidence on Efficacy and Safety of Chinese Medicines Combined Western Medicines Treatment for Breast Cancer With Endocrine Therapy. Frontiers in Oncology. 11. 661925–661925. 7 indexed citations
5.
Li, Weiping, Liguang Yang, Qiang He, et al.. (2019). A Homeostatic Arid1a-Dependent Permissive Chromatin State Licenses Hepatocyte Responsiveness to Liver-Injury-Associated YAP Signaling. Cell stem cell. 25(1). 54–68.e5. 88 indexed citations
6.
Lu, Li, Ling Tang, Bo Liang, et al.. (2019). Evaluation of in vitro embryotoxicity tests for Chinese herbal medicines. Reproductive Toxicology. 89. 45–53. 6 indexed citations
7.
Li, Lili, Yichao Fan, Jie Luo, et al.. (2019). Tumor Suppression of Ras GTPase-Activating Protein RASA5 through Antagonizing Ras Signaling Perturbation in Carcinomas. iScience. 21. 1–18. 13 indexed citations
8.
Lu, Li, et al.. (2018). Post-transcriptional regulation of miRNA-15a and miRNA-15b on VEGFR gene and deer antler cell proliferation. Turkish Journal of Biochemistry. 44(3). 354–362. 2 indexed citations
9.
Lu, Li, Milton J. Finegold, & Randy L. Johnson. (2018). Hippo pathway coactivators Yap and Taz are required to coordinate mammalian liver regeneration. Experimental & Molecular Medicine. 50(1). e423–e423. 128 indexed citations
10.
Mu, Junhao, Lili Li, Zhenfang Du, et al.. (2017). Dickkopf-related protein 2 induces G0/G1 arrest and apoptosis through suppressing Wnt/β-catenin signaling and is frequently methylated in breast cancer. Oncotarget. 8(24). 39443–39459. 28 indexed citations
11.
Liu, Bei, Jinfeng Ding, Jian Luo, et al.. (2016). Seven protective miRNA signatures for prognosis of cervical cancer. Oncotarget. 7(35). 56690–56698. 21 indexed citations
12.
Kim, Jin Young, et al.. (2014). Dual function of Yap in the regulation of lens progenitor cells and cellular polarity. Developmental Biology. 386(2). 281–290. 38 indexed citations
14.
Deng, Yan, Chi Chiu Wang, Kwong Wai Choy, et al.. (2014). Therapeutic potentials of gene silencing by RNA interference: Principles, challenges, and new strategies. Gene. 538(2). 217–227. 230 indexed citations
15.
Zhou, Lei, Yu Liu, Li Lu, Xin-zheng Lu, & Richard A. F. Dixon. (2012). Cardiac Gene Activation Analysis in Mammalian Non-Myoblasic Cells by Nkx2-5, Tbx5, Gata4 and Myocd. PLoS ONE. 7(10). e48028–e48028. 30 indexed citations
16.
Lu, Li, Ying Li, Soo Mi Kim, et al.. (2010). Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proceedings of the National Academy of Sciences. 107(4). 1437–1442. 586 indexed citations breakdown →
17.
Thenappan, Arun, Vivek Shukla, Ying Li, et al.. (2010). Loss of transforming growth factor β adaptor protein β-2 spectrin leads to delayed liver regeneration in mice. Hepatology. 53(5). 1641–1650. 32 indexed citations
19.
Zhang, Yi, Qifa Ye, Li Lu, et al.. (2005). Panax notoginseng saponins preconditioning protects rat liver grafts from ischemia/reperfusion injury via an antiapoptotic pathway.. PubMed. 4(2). 207–12. 19 indexed citations
20.
Lu, Li. (2001). Chromosome Number of Sladenia celastrifolia. Acta Botanica Yunnanica. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026